Mahamaya Lifesciences fundamental analysis

MAHALIFE

191.6

3.40 (-1.74%)
Last updated on 6 Feb, 2026 | 15:21 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Mahamaya Lifesciences Fundamentals

P/E Ratio

35.26

P/B Ratio

4.01

Div. Yield

0

Sector P/E

40.79

Sector P/B

2.28

Sec. Div. Yield

0.35

Mahamaya Lifesciences Fundamentals is currently trading with a P/E Ratio of 35.26, compared to the sector average of 40.79. Its P/B Ratio stands at 4.01, while the sector’s is 2.28. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.35%.

Mahamaya Lifesciences Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Good

On its scorecard, Mahamaya Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.